pomalidomide,lenalidomide
bms
['pomalyst', 'revlimid']
 agreed - i haven t changed my default of revlimid maintenance based on this. but, as in that paper, for patients with a personal history or strong risk factors for non-myeloma cancers, i might consider pomalyst!
Asst Professor @UWMedicine @fredhutch, s/p @PennIMResidents ??@UCSFCancer training. Myeloma #MMsm #cellphonesandcelltherapies ????

COI: https://t.co/3Uuojuio6R